Maunank Shah
Johns Hopkins University, MD·Medicine & Clinical Research
Two infectious diseases, HIV and tuberculosis (TB), depend on people completing long treatments and on having enough trained clinicians. These projects test practical, scalable ways to strengthen care.
- Fields
Medicine & Clinical Research
Public Health & Epidemiology
Education Research
- Topics
HIV workforce
continuing medical education
artificial intelligence
- Grants
- 3 known grants, through May 2028
What they work on
- Evaluate the accuracy and consistency of HIV clinical cases and responses generated by PRISM-HIV, a large language model tool that simulates a faculty mentor for case-based learning.
- Assess the acceptability and usability of PRISM-HIV among internal medicine residents, primary care providers and HIV clinicians using mixed quantitative and qualitative methods.
- Compare PRISM-HIV-enhanced learning with lecture-based learning alone in a hybrid implementation-effectiveness trial, measuring knowledge, self-confidence and RE-AIM implementation outcomes.
- Test whether smartphone video-directly observed therapy, with or without weekly financial incentives, increases completion of latent TB treatment among 399 Baltimore adults, measured with electronic MEMS pill caps.
- Determine the costs, budget impact and incremental cost-effectiveness of video-observed therapy and incentive interventions for latent TB.
- Expand access for early-stage TB investigators to patient cohorts, biospecimen repositories and study coordination through the Johns Hopkins TRAC Clinical Core.
More about the research
One uses artificial intelligence to train HIV clinicians. Another uses smartphones and financial incentives to help patients finish TB-prevention therapy. A third builds shared infrastructure for TB clinical research. Together they focus on delivering care and building capacity in clinical settings.
Why it matters
PRISM-HIV could offer a scalable way to train more clinicians in HIV care with little faculty time, helping to address shortages in access to HIV treatment. Smartphone video monitoring and incentives could help high-risk patients in Baltimore and elsewhere finish latent TB treatment, preventing active TB and supporting TB elimination. The core expands the pipeline of TB clinical researchers.
Known grants
From NIH and NSF research grants. Labs often have other funding we can't see.
Closest labs
William Smith
University of North Carolina at Chapel Hill, NC·Medicine & Clinical Research·Early-career
Identify facilitators and barriers to using behavioral economic and financial incentive strategies for patients leaving Coordinated Specialty Care for first-episode psychosis, guided by a stakeholder steering committee.
Mushtaq Ahmed
University of Chicago, IL·Microbiology & Immunology
Determine whether bone morphogenetic protein (BMP) signaling, a lung development and repair pathway, is required to control Mycobacterium tuberculosis and prevent reactivation of latent TB.
Adrienne Shapiro
University of Washington, WA·Public Health & Epidemiology
Test whether differentiated service delivery with multi-month dispensing produces higher completion of tuberculosis preventive therapy than clinic standard of care, in a randomized controlled trial among household contacts of people with TB and people with HIV in Kenya.
The school
Johns Hopkins University: 100 labs on PI Pages, $4.1B a year on research, 622 research doctorates a year.
Reach out
A start for your email. Fill in the brackets.